Pan-cancer analysis

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Pan-cancer analysis

Apr 13, 2024, 08:20 | Blog

Joris van de Haar: We characterize the microbial DNA in metastatic cancers with unprecedented accuracy, breath and depth

Joris van de Haar, Translational Research and Precision Medicine Working Group at ESMO, shared a post…

Sep 3, 2023, 17:28 | Insight

Jess Scott: More benefits of exercise - pan-cancer analysis of more than 11,000 patients.

Jess Scott, an exercise oncology researcher at Memorial Sloan Kettering Cancer Center, recently tweeted: "More…

Aug 16, 2023, 19:25 | Blog

Anirban Maitra: Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation.

As Anirban Maitra, Professor of Pathology and Translational Molecular Pathology stated on Twitter: "More “gifts”…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023